US20080194481A1 - Albumin Fusion Proteins - Google Patents

Albumin Fusion Proteins Download PDF

Info

Publication number
US20080194481A1
US20080194481A1 US11/932,823 US93282307A US2008194481A1 US 20080194481 A1 US20080194481 A1 US 20080194481A1 US 93282307 A US93282307 A US 93282307A US 2008194481 A1 US2008194481 A1 US 2008194481A1
Authority
US
United States
Prior art keywords
albumin fusion
albumin
invention
hsa
fusion protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/932,823
Inventor
Craig A. Rosen
Adam Bell
Paul A. Moore
Yanggu Shi
David LaFleur
Jason B. Bock
Michael W. Laird
William A. Haseltine
Douglas B. Woods
Mani Subramanian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US34181101P priority Critical
Priority to US35035802P priority
Priority to US35136002P priority
Priority to US35937002P priority
Priority to US36000002P priority
Priority to US36750002P priority
Priority to US37022702P priority
Priority to US37895002P priority
Priority to US38261702P priority
Priority to US38312302P priority
Priority to US38570802P priority
Priority to US39462502P priority
Priority to US39800802P priority
Priority to US40213102P priority
Priority to US40270802P priority
Priority to US41142602P priority
Priority to US41135502P priority
Priority to US41498402P priority
Priority to US41761102P priority
Priority to US42024602P priority
Priority to US42362302P priority
Priority to PCT/US2002/040891 priority patent/WO2003060071A2/en
Priority to US44130503P priority
Priority to US45320103P priority
Priority to US46722203P priority
Priority to US47281603P priority
Priority to US47626703P priority
Priority to US50517203P priority
Priority to US50674603P priority
Priority to PCT/US2004/001369 priority patent/WO2005003296A2/en
Priority to US54227404P priority
Priority to US10/775,204 priority patent/US7141547B2/en
Priority to US54990104P priority
Priority to US55690604P priority
Priority to US63660304P priority
Priority to PCT/US2005/004041 priority patent/WO2005077042A2/en
Priority to US11/175,690 priority patent/US7521424B2/en
Priority to US70752105P priority
Priority to US71238605P priority
Priority to US73272405P priority
Priority to US77691406P priority
Priority to US78136106P priority
Priority to US11/429,276 priority patent/US7592010B2/en
Priority to US81018206P priority
Priority to US81368206P priority
Priority to US11/495,624 priority patent/US20080004206A1/en
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Priority to US11/932,823 priority patent/US20080194481A1/en
Assigned to HUMAN GENOME SCIENCES, INC. reassignment HUMAN GENOME SCIENCES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HASELTINE, WILLIAM A., MOORE, PAUL A., SHI, YANGGU, BOCK, JASON B., ROSEN, CRAIG A., BELL, ADAM, LAIRD, MICHAEL W., WOODS, DOUGLAS B., LAFLEUR, DAVID, SUBRAMANIAN, MANI
Publication of US20080194481A1 publication Critical patent/US20080194481A1/en
Application status is Abandoned legal-status Critical

Links